‘Auric’ Relied On Amazon Reviews For Research Claims To Cure Fatty Liver

Ranchi : Patanjali’s case is going on in the Supreme Court for misleading people by showing misleading advertisements. But there are many other pharmaceutical companies in this category.

In fact, the Supreme Court has recently reprimanded Patanjali Ayurveda for misleading advertisements. Besides, the court has also ordered Baba Ramdev and Acharya Balakrishna to apologise. The case will be heard again on April 23.

Regarding another such case, Ranchi’s famous and young Dr. Anuj has posted a post on social media X. Which needs to be read and thought about and made aware.

Dr. Anuj has written, there is a company named Auric which itself manufactures Ayurvedic nutraceutical products. It has claimed in the advertisement of this company that it completely cures fatty liver within 60 days. It also claims to completely cure lung problems caused by cigarettes and other intoxicants. It claims to call its products in Nutraceuticals category.

They say that they have launched these products in the market after doing a lot of research. If these are nutraceuticals then how are they claiming to cure the disease? Does this not fall in the category of misleading advertising?

When he was asked to share his research, he said that he has reviews on Amazon . Are Amazon and Google’s reviews research articles for them? What is the compulsion of FSSAI that all these misleading companies have been given free rein to play with people’s health?

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?